{"product_id":"hormonal-contraceptive-market-global-industry-trends-share-size-growth-opportunity-and-forecast-2022-2027","title":"Hormonal Contraceptive Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027","description":"\u003cp\u003eHormonal Contraceptive Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027\u003c\/p\u003e\n\n\u003cp\u003eThe global hormonal contraceptive market size reached US$ 17.0 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 22.2 Billion by 2027, exhibiting a growth rate (CAGR) of 4.81% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.\u003c\/p\u003e\n\n\u003cp\u003eHormonal contraceptives are formulations of progestin or a combination of estrogen and progesterone hormones. They act on the endocrine system to prevent ovulation and fertilization. As a result, they are used for preventing unwanted pregnancies and are also known to relieve period pain and often result in lighter periods. Hormonal contraceptives are considered one of the most effective methods, which can be taken before and after vaginal intercourse. They include birth control pills, vaginal rings, contraceptive skin patches, and hormone-releasing contraceptive coils. Hormonal contraceptives also affect the womb lining, making it hard for the fertilized eggs to be implanted.\u003c\/p\u003e\n\n\u003cp\u003eHormonal Contraceptive Market Trends:\u003cbr\u003e\nThe global hormonal contraceptive market is primarily driven by the increasing awareness among the masses regarding family planning. This has facilitated the need to prevent unintended pregnancies, especially among young couples. Furthermore, a significant rise in health issues associated with teenage pregnancies is promoting the use of contraceptives as they are easily accessible. Governments of different countries are also adopting various initiatives to support and improve access to these products by promoting affordable and high-quality healthcare services. Besides this, the advancements in the healthcare industry have resulted in the production of innovative products such as hormonal patches, implants, intrauterine devices, and drug-device combination products. These devices have fewer side effects and enhanced levels of efficiency in preventing pregnancy, which is favorably influencing the growth of the market.\u003c\/p\u003e\n\n\u003cp\u003eKey Market Segmentation:\u003cbr\u003e\nIMARC Group provides an analysis of the key trends in each sub-segment of the global hormonal contraceptive market report, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on product, hormone, age group and end user.\u003c\/p\u003e\n\n\u003cp\u003eBreakup by Product:\u003c\/p\u003e\n\n\u003cp\u003eOral Contraceptive Pills\u003cbr\u003e\nIntrauterine Device (IUD)\u003cbr\u003e\nInjectable Birth Control\u003cbr\u003e\nVaginal Rings\u003cbr\u003e\nOthers\u003cbr\u003e\n \u003cbr\u003e\nBreakup by Hormone:\u003c\/p\u003e\n\n\u003cp\u003eProgestin-only Contraceptive\u003cbr\u003e\nCombined Hormonal Contraceptive\u003cbr\u003e\n \u003cbr\u003e\nBreakup by Age Group:\u003c\/p\u003e\n\n\u003cp\u003e15-24 Years\u003cbr\u003e\n25-34 Years\u003cbr\u003e\n35-44 Years\u003cbr\u003e\nAbove 44 Years\u003cbr\u003e\n \u003cbr\u003e\nBreakup by End User:\u003c\/p\u003e\n\n\u003cp\u003eHospitals and Clinics\u003cbr\u003e\nHomecare\u003cbr\u003e\nAmbulatory Surgical Centers\u003cbr\u003e\nOthers\u003cbr\u003e\n \u003cbr\u003e\nBreakup by Region:\u003c\/p\u003e\n\n\u003cp\u003eNorth America\u003cbr\u003e\nUnited States\u003cbr\u003e\nCanada\u003cbr\u003e\nAsia-Pacific\u003cbr\u003e\nChina\u003cbr\u003e\nJapan\u003cbr\u003e\nIndia\u003cbr\u003e\nSouth Korea\u003cbr\u003e\nAustralia\u003cbr\u003e\nIndonesia\u003cbr\u003e\nOthers\u003cbr\u003e\nEurope\u003cbr\u003e\nGermany\u003cbr\u003e\nFrance\u003cbr\u003e\nUnited Kingdom\u003cbr\u003e\nItaly\u003cbr\u003e\nSpain\u003cbr\u003e\nRussia\u003cbr\u003e\nOthers\u003cbr\u003e\nLatin America\u003cbr\u003e\nBrazil\u003cbr\u003e\nMexico\u003cbr\u003e\nOthers\u003cbr\u003e\nMiddle East and Africa\u003cbr\u003e\n \u003cbr\u003e\nCompetitive Landscape:\u003cbr\u003e\nThe competitive landscape of the industry has also been examined along with the profiles of the key players being Afaxys Inc., Agile Therapeutics Inc., Allergan Inc. (AbbVie Inc.), Bayer AG, Cipla Limited, Johnson \u0026amp; Johnson, Merck \u0026amp; Co. Inc., Pfizer Inc., Piramal Group and Teva Pharmaceutical Industries Ltd.\u003c\/p\u003e\n\n\u003cp\u003eKey Questions Answered in This Report:\u003cbr\u003e\nHow has the global hormonal contraceptive market performed so far and how will it perform in the coming years?\u003cbr\u003e\nWhat has been the impact of COVID-19 on the global hormonal contraceptive market?\u003cbr\u003e\nWhat are the key regional markets?\u003cbr\u003e\nWhat is the breakup of the market based on the product?\u003cbr\u003e\nWhat is the breakup of the market based on the hormone?\u003cbr\u003e\nWhat is the breakup of the market based on the age group?\u003cbr\u003e\nWhat is the breakup of the market based on the end user?\u003cbr\u003e\nWhat are the various stages in the value chain of the industry?\u003cbr\u003e\nWhat are the key driving factors and challenges in the industry?\u003cbr\u003e\nWhat is the structure of the global hormonal contraceptive market and who are the key players?\u003cbr\u003e\nWhat is the degree of competition in the industry?\u003c\/p\u003e","brand":"Marketing \u0026 Market Research","offers":[{"title":"October, 2022 \/ 145 Pages \/ MCW16259705","offer_id":47696747004210,"sku":null,"price":2999.0,"currency_code":"USD","in_stock":true}],"url":"https:\/\/www.hardmanwell.com\/products\/hormonal-contraceptive-market-global-industry-trends-share-size-growth-opportunity-and-forecast-2022-2027","provider":"HARDMAN AND WELL MANAGEMENT CONSULTANCIES L.L.C","version":"1.0","type":"link"}